The role of behavioral conditioning in the development of nausea

American Journal of Obstetrics and Gynecology

Volumn 186, Issue 5, 2002, Pages

  Matteson, Sara ^a   Roscoe, Joseph ^a   Hickok, Jane ^a   Morrow, Gary R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Anticipatory; Chemotherapy; Morning sickness; Nausea and vomiting

Indexed keywords

ALPRAZOLAM; BUTYROPHENONE; CHLORPROMAZINE; HALOPERIDOL; PHENOTHIAZINE; PROCHLORPERAZINE MALEATE; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; ANTINEOPLASTIC AGENT;

BEHAVIOR THERAPY; COGNITIVE THERAPY; CONDITIONING; CONFERENCE PAPER; DESENSITIZATION; DISEASE MODEL; EXPECTATION; HYPNOSIS; NAUSEA; NAUSEA AND VOMITING; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SELF CONTROL; HUMAN; REVIEW; VOMITING;

ANTINEOPLASTIC AGENTS; HUMANS; NAUSEA; PREVALENCE; VOMITING;

EID: 0036584673     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.122597     Document Type: Conference Paper

References (54)

1. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens
2. Nausea and vomiting remain a significant clinical problem: Trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices
3. Conditioned aversive responses in cancer chemotherapy patients: Theoretical and developmental analysis
4. Hyperemesis gravidarum
5. Nausea and vomiting in pregnancy
6. Gastric dysrhythmias and nausea of pregnancy
7. Managing chemotherapy-related nausea and vomiting: The state of the art
8. Anticipatory nausea and vomiting in cancer patients
9. Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting
10. Nausea and vomiting in pregnancy: A review of the problem with particular regard to psychological and social aspects
11. Acupressure therapy for morning sickness. A controlled clinical trial
12. Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer
13. Postchemotherapy nausea and vomiting in cancer patients receiving outpatient chemotherapy
14. Expectation and occurrence of postchemotherapy side effects: Nausea and vomiting
15. Patient expectations as predictor of chemotherapy-induced nausea
16. Development of anticipatory nausea: A prospective analysis
17. The development of anticipatory nausea in patients receiving adjuvant chemotherapy for breast cancer
18. Cardiovascular conditioning and anticipatory nausea and vomiting in cancer patients
19. A longitudinal study of the development of anticipatory nausea and vomiting in cancer chemotherapy patients: The role of absorption and autonomic perception
20. Conditioned nausea after cancer chemotherapy and autonomic nervous system conditionability
21. Etiology and treatment of the psychological side effects associated with cancer chemotherapy: A critical review and discussion
22. Predicting development of anticipatory nausea in cancer patients: Prospective examination of eight clinical characteristics
23. Chemotherapy-related nausea and vomiting: Etiology and management
24. The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: A review and synthesis
25. The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis
26. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism
27. NCCN antiemesis practice guidelines
28. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting
29. Comparison of the 5-hydroxytryptamine (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis
30. Progress in reducing anticipatory nausea and vomiting: A study of community practice
31. Anticipatory nausea and vomiting with chemotherapy
32. Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin
33. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy
34. Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists
35. Post-treatment use of relaxation training by cancer patients
36. Effectiveness of biofeedback and relaxation training in reducing the side effects of cancer chemotherapy
37. Effects of coping style and relaxation on cancer chemotherapy side effects and emotional responses
38. Effectiveness of relaxation training in reducing the aversiveness of chemotherapy in the treatment of cancer
39. Effect of the cognitive hierarchy in the systematic desensitization treatment of anticipatory nausea in cancer patients: A component comparison with relaxation only, counseling, and no treatment
40. Behavioral intervention in cancer treatment: Controlling aversion reactions to chemotherapy
41. The treatment of hyperemesis gravidarum with hypnotherapy
42. The psychosomatic treatment of hyperemesis gravidarum by hypnosis
43. Self-hypnosis as antiemetic therapy in children receiving chemotherapy
44. The use of self-hypnosis by children with cancer
45. Hypnosis for reduction of vomiting associated with chemotherapy and disease in adolescents with cancer
46. Effects of video games on the adverse corollaries of chemotherapy in pediatric oncology patients: A single-case analysis
47. Cognitive/attentional distraction in the control of conditioned nausea in pediatric cancer patients receiving chemotherapy
48. Behavioural interventions and psychological aspects of care during chemotherapy
49. Patients' pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea